National Research Corporation (NRC) To Go Ex-Dividend on June 26th

National Research Corporation (NASDAQ:NRC) declared a quarterly dividend on Wednesday, April 15th. Investors of record on Friday, June 26th will be given a dividend of 0.16 per share on Friday, July 10th. This represents a c) annualized dividend and a dividend yield of 3.2%. The ex-dividend date of this dividend is Friday, June 26th.

National Research has increased its dividend payment by an average of 0.2%per year over the last three years.

National Research Stock Performance

Shares of NASDAQ:NRC opened at $20.04 on Wednesday. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52. The business’s fifty day moving average price is $18.56 and its two-hundred day moving average price is $17.71. National Research has a fifty-two week low of $11.01 and a fifty-two week high of $22.79. The stock has a market capitalization of $455.91 million, a price-to-earnings ratio of 51.38 and a beta of 0.37.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.The company had revenue of $34.80 million during the quarter.

Institutional Trading of National Research

A number of hedge funds and other institutional investors have recently modified their holdings of NRC. Bank of America Corp DE raised its position in shares of National Research by 3.0% during the first quarter. Bank of America Corp DE now owns 112,468 shares of the company’s stock worth $1,910,000 after acquiring an additional 3,323 shares during the last quarter. Empowered Funds LLC bought a new position in National Research in the first quarter valued at about $226,000. Quantinno Capital Management LP increased its position in National Research by 61.3% in the first quarter. Quantinno Capital Management LP now owns 62,329 shares of the company’s stock worth $1,058,000 after purchasing an additional 23,682 shares during the period. Bank of New York Mellon Corp increased its position in National Research by 4.0% in the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock worth $4,257,000 after purchasing an additional 9,730 shares during the period. Finally, Fifth Third Bancorp bought a new stake in National Research during the 1st quarter worth about $1,531,000. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.